HMG-CoA Reductase

(Rac)-5-Keto Fluvastatin is a specific impurity of Fluvastatin, functioning primarily as an HMG-CoA reductase inhibitor. With an IC50 value of 8 nM, it demonstrates potent inhibitory activity against this key enzyme involved in cholesterol biosynthesis. This compound is useful for studies focused on lipid metabolism and cardiovascular research, enabling the investigation of statin-related mechanisms and effects.

L-669,262 is a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, exhibiting an IC50 of 0.10 ng/mL in rat liver preparations. This compound effectively downregulates cholesterol synthesis, making it a valuable tool in lipid metabolism research and studies focused on cardiovascular disease. Its specificity and high potency facilitate a wide range of applications in pharmacological studies and drug development targeting dyslipidemia.

Pitavastatin magnesium is a potent HMG-CoA reductase inhibitor that plays a critical role in lipid metabolism. It effectively reduces total cholesterol and low-density lipoprotein cholesterol levels, as demonstrated in hyperlipidemic rat models. This compound is valuable for research focused on cardiovascular and cerebrovascular diseases, particularly in studies investigating hyperlipidemia and its associated conditions.

L 668411 is a β-lactone compound that acts as an inhibitor of HMG-CoA Reductase (HMGCR), targeting cholesterol biosynthesis. It effectively inhibits rat liver cytosolic 3-hydroxy-3-methylglutaryl-CoA synthase and reduces [14C] acetate incorporation into sterols in Hep G2 cell cultures. The inhibition demonstrates an irreversible mechanism in cellular systems, while exhibiting reversible properties in cultured cells and animal models, making it a valuable tool for studying cholesterol metabolism and related diseases.

Tenivastatin calcium is an HMG-CoA reductase inhibitor that effectively lowers cholesterol levels by inhibiting the rate-limiting step in cholesterol biosynthesis. This compound has potential applications in the study of hyperlipidemia and cardiovascular disease, providing insights into lipid metabolism and associated disorders. Researchers can utilize Tenivastatin calcium to explore therapeutic strategies aimed at managing lipid abnormalities.

Glenvastatin is a potent inhibitor of HMG-CoA reductase, an enzyme critical in the cholesterol biosynthesis pathway. This compound effectively reduces plasma levels of total cholesterol and phospholipids, as well as liver cholesterol content, without increasing cholesterol or total bile acids in gallbladder bile. Glenvastatin is valuable for research focused on hyperlipidemia and related metabolic disorders.

(3S,5R)-Fluvastatin-d6 sodium is a deuterium-labeled derivative of the HMG-CoA reductase inhibitor, (3S,5R)-Fluvastatin. This compound exhibits a potent inhibitory activity with an IC50 of 8 nM, making it valuable for studying cholesterol biosynthesis. In addition to its role in lipid regulation, Fluvastatin has been shown to protect vascular smooth muscle cells from oxidative stress via the Nrf2-dependent antioxidant pathway, offering insights for cardiovascular research applications.

Dalvastatin is a potent inhibitor of HMG-CoA reductase, a key enzyme involved in cholesterol biosynthesis. By effectively reducing cholesterol levels, Dalvastatin demonstrates significant potential in the management of hyperlipidemia and related cardiovascular conditions. Its ability to modulate lipid profiles makes it a valuable tool for research into lipid metabolism and cardiovascular disease therapeutics.

GR 92549 is a potent, orally active inhibitor of HMG-CoA reductase, targeting the enzyme responsible for cholesterol biosynthesis. This compound effectively reduces cholesterol levels and may serve as a significant tool in metabolic and cardiovascular research. Its capability to modulate cholesterol metabolism makes it valuable for studies related to dyslipidemia and atherosclerosis.

((3R,5R,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate) calcium(II) is a control compound associated with HMG-CoA reductase (HMGCR), a key enzyme involved in cholesterol biosynthesis. This compound serves as an impurity marker in the analysis of Rosuvastatin, an established HMGCR inhibitor. Its role in research applications includes evaluating batch consistency and the purity of statin formulations, facilitating the development and quality control of lipid-lowering therapeutics.

Rawsonol is a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, a key enzyme in the cholesterol biosynthesis pathway. Derived from the green alga Avrainuika rawsoni, Rawsonol demonstrates significant inhibitory activity, making it a valuable tool for research investigating cholesterol regulation and related metabolic pathways. Its role as an HMGCR inhibitor positions it for applications in studies of lipid metabolism and cardiovascular health.

(3S,5R)-Pitavastatin calcium functions primarily as an inhibitor of HMG-CoA reductase, a key enzyme in cholesterol biosynthesis. This enantiomer exhibits significant lipid-lowering activity, making it valuable for research into dyslipidemia and cardiovascular disease. Its efficacy in modulating lipid profiles has led to its application in studies focused on metabolic disorders and therapeutic approaches for hypercholesterolemia.

Acetoacetyl-CoA is a key precursor of HMG-CoA in the mevalonate pathway, playing a crucial role in cholesterol biosynthesis. It is generated through the action of acetoacetyl-CoA thiolase, which catalyzes the condensation of two acetyl-CoA molecules. Additionally, acetoacetyl-CoA serves as an important intermediate in the metabolism of fatty acids, contributing to both their breakdown and synthesis. This compound is valuable for research in lipid metabolism and the regulation of cholesterol levels.

DL-3-Hydroxy-3-methylglutaryl coenzyme A disodium hydrate is a disodium salt of HMG-CoA, functioning as a key intermediate in the biosynthesis of terpenes and ketone bodies. This compound plays a crucial role in lipid metabolism by serving as a precursor for cholesterol synthesis and modulating cholesterol levels through interaction with the low-density lipoprotein (LDL) receptor. Its applications include studying lipid metabolism, cholesterol regulation, and related metabolic pathways in various biological systems.

(3R,5R)-Rosuvastatin Lactone is an HMG-CoA reductase inhibitor that plays a crucial role in cholesterol biosynthesis modification. This compound exhibits potent lipid-lowering effects, making it valuable for studying dyslipidemia and related cardiovascular diseases. Its applications extend to elucidating mechanisms of action in statin therapies and examining its impact on metabolic pathways.